Impact of anesthetic agents on overall and recurrence-free survival in patients undergoing esophageal cancer surgery: A retrospective observational study-Reference-Cited by-同舟云学术

Impact of anesthetic agents on overall and recurrence-free survival in patients undergoing esophageal cancer surgery: A retrospective observational study

Published:2017-10-25 Issue:1 Volume:7 Page:
ISSN:2045-2322
Container-title:Scientific Reports
language:en
Short-container-title:Sci Rep

Author:

Jun In-Jung,Jo Jun-Young,Kim Jong-Il,Chin Ji-Hyun,Kim Wook-Jong,Kim Hyeong Ryul,Lee Eun-Ho^ORCID,Choi In-Cheol

Publisher

Springer Science and Business Media LLC

Subject

Multidisciplinary

Link

http://www.nature.com/articles/s41598-017-14147-9.pdf

Reference32 articles.

1. D’Amico, T. A. Outcomes after surgery for esophageal cancer. Gastrointest Cancer Res 1, 188–196 (2007).

2. Huang, F. L. & Yu, S. J. Esophageal cancer: Risk factors, genetic association, and treatment. Asian J Surg (2016).

3. Halsted, W. S. I. The Results of Radical Operations for the Cure of Carcinoma of the Breast. Ann Surg 46, 1–19 (1907).

4. van der Bij, G. J. et al. The perioperative period is an underutilized window of therapeutic opportunity in patients with colorectal cancer. Ann Surg 249, 727–734 (2009).

5. Gottschalk, A. et al. Review article: the role of the perioperative period in recurrence after cancer surgery. Anesth Analg 110, 1636–1643 (2010).

Cited by 109 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Recurrence-free survival after curative resection of non-small cell lung cancer between inhalational gas anesthesia and propofol-based total intravenous anesthesia: a multicenter, randomized, clinical trial (GAS TIVA trial): protocol description;Perioperative Medicine;2024-07-23

2. Mechanism of isoflurane‑mediated breast cancer growth in vivo;Oncology Letters;2024-04-30

3. Anesthesia and cancer recurrence: a narrative review;Anesthesia and Pain Medicine;2024-04-30

4. Are there beneficial effects to hybrid anesthesia*?;Journal of Anesthesia;2024-03-29

5. Anti‐inflammatory potential of remimazolam: A laboratory and clinical investigation;Immunity, Inflammation and Disease;2024-03